ArticleLung2021

Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study.

Marcia A Friedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.